Here, we found that formate, an essential one-carbon metabolite, activates superoxide (O production is not associated with cytochrome c oxidase (COX) inhibition or changes in membrane potential and NAD(P)H levels. Sodium formate supplementation increases phosphorylating respiration without altering proton leaks. Finally, it was observed that the 2-oxoglutarate dehydrogenase (OGDH) inhibitors 3-methyl-2-oxovaleric acid (KMV) and CPI-613 inhibit the formate-induced increase in pyruvate-driven ROS production. The importance of these findings in one-carbon metabolism and physiology are discussed herein.
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Keywords: mitochondria; one-carbon metabolism; reactive oxygen species Neural tube defects (NTDs) comprise a group of very serious developmental diseases, characterized by impaired closing of the neural tube, the precursor to the vertebrate brain. There are a variety of NTDs depending on the site of the impairment. Among the most common are anencephaly and spina bifida. Anencephaly involves the loss of a major portion of the brain when the rostral end of the neural tube fails to close. In spina bifida the defect is largely associated with the spinal cord. NTDs are associated with low folate status and with polymorphisms in certain genes of folate metabolism [1] . Folate (Vitamin B 9 ) is a critical component of one-carbon metabolism, a complex series of reactions whereby one-carbon groups at different oxidation states (formyl, methylene, methyl) are used in the synthesis of key molecules. This includes the synthesis of nucleic acids (purines and thymidylate) and S-adenosylmethionine (SAM) which is required for a large number of methylation reactions [2] , including the methylation of cytosine bases in DNA. This latter phenomenon serves as a key mechanism in the regulation of gene expression. Mandatory fortification of the food supply with folic acid (a synthetic analog of folate) was introduced into the USA, Canada and Costa Rica in 1998, resulting in declines in the incidence of NTDs in these countries of 30 to 50% [3] . Since then approximately 80 countries, world-wide, have adopted folic acid fortification.
Given the complexity of neural tube closure it is not surprising that not all NTDs are preventable by folic acid fortification. There appears to be a "floor effect" where additional folic acid does not further decrease the incidence of NTDs [4] . Recent experiments have pointed to formate as a possible preventative agent for folic acid-resistant NTDs. Formate, the only one-carbon metabolite not linked to tetrahydrofolate (THF), has emerged as a critical molecule in one-carbon metabolism [3] . It is principally produced in mitochondria from serine and glycine as well as from choline catabolism, dimethylglycine and sarcosine. Formate exits the mitochondria by an unknown mechanism and can be converted to 10-formyl-THF in the cytosol. Knockout of the mitochondrial MTHFD1L (the gene which specifies the mitochondrial enzyme which produces formate) in mice is embryonically lethal, the embryos being characterized by both NTDs and a growth defect. The provision of formate in the drinking water of the pregnant dams reduced the severity of the NTDs but it was still embryonic lethal [5] . Knockout of Gldc, which codes for a subunit of the glycine cleavage system, results in an appreciable number of NTDs which can be entirely prevented by the provision of formate in the dams' drinking water [6] . Finally, the incidence of NTDs in the curly tailed mouse can also be substantially reduced by the provision of formate in the dams' drinking water [7] . Although the precise genetic lesion in these animals has not been established, they do have reduced expression of Mthfd1 l (7). These experiments have led Sudiwala et al. [7] to the suggestion that formate may be a useful therapy for the prevention of folic acid-resistant NTDs. Before this can be contemplated, the issue of potential toxicity of formate needs to be addressed.
Mitochondria play a vital role in the provision and oxidation of one-carbon groups that are required for cell division, growth, and signaling. One-carbon donors like choline and dimethylglycine are oxidizable substrates for mitochondria that can support oxidative phosphorylation and ROS production [8] . Mitochondria are also important sites for formate metabolism [3, 9] . It has also been reported that high levels of formate can interfere with mitochondrial metabolism by inhibiting COX activity which could alter ROS production by the electron transport chain [10] . These high formate concentrations are often encountered during methanol toxicity. We therefore suggest that it is timely to revisit the issue of mitochondrial formate toxicity, examining not only respiration but also the effect of formate on the mitochondrial production of reactive oxygen species.
Materials and methods

Reagents
Pyruvate dehydrogenase (PDH) and 2-oxoglutarate dehydrogenase (OGDH) of porcine heart origin, thiamine pyrophosphate (TPP), coenzyme A (CoASH), NAD + , Sodium formate, H 2 O 2 (30% solution), NADH, mannitol, HEPES, sucrose, EGTA, fatty acid-free bovine serum albumin, Bradford reagent, superoxide dismutase (SOD), myxothiazol, 3-methyl-2-keto valeric acid (KMV), CPI-613, tetramethylrhodamine ethyl (TMRE), antimycin A, adenosine diphosphate (ADP), oligomycin, pyruvate, 2-oxoglutarate, malate, succinate, N, N, N', N' -tetramethyl pphenylene diamide (TMPD), ascorbic acid, and horse radish peroxidase (HRP) were purchased from Sigma. Amplex Ultra Red (AUR) reagent was acquired from Invitrogen. Heparin was purchased from Fresenius Kabi Canada.
Isolation of liver mitochondria
All animal experiments were approved by Memorial University's Institutional Animal Care and Use Committee. All steps were performed on ice or at 4°C. Mitochondria were enriched from the livers of male C57BL/6N mice purchased from Charles River Laboratories. Mice (9-10 weeks old) were euthanized by cerebral dislocation under isoflurane anesthesia and livers placed in ice-cold mannitol (220 mM), EGTA (1 mM), sucrose (70 mM), and HEPES (10 mM) buffer supplemented with 0.5% fatty acid-free BSA (abbreviated MESH-B buffer). The buffer was adjusted to a pH of 7.4 using KOH. Livers were cut into small pieces and washed three times with ice-cold MESH-B to remove excess blood and fat. Livers were chopped on a Teflon watch glass and then homogenized in 15 mL icecold MESH-B using the Potter-Elvejham method. Homogenates were then centrifuged at 800 9 g for 9 min to remove any undisrupted tissue and nuclei. Fat was carefully skimmed from the top and then the supernatant was centrifuged at 12 000 9 g for 9 min to yield a mitochondrial pellet. The supernatant was decanted and the sides of the tube were wiped with a Kimwipe to remove any residual fat. The pellet was resuspended in 15 mL MESH-B and centrifuged at 12 000 9 g for 9 min. The final pellet was resuspended in 500 lL MESH devoid of BSA. The mitochondrial protein concentration was determined by Bradford assay using BSA as a standard. The final concentration of protein in the mitochondrial preparation was~15 mgÁmL À1 .
Fluorometric measurement of O
ÁÀ
/H O production
Hydrogen peroxide production was tracked fluorometrically using the Amplex UltraRed (AUR) assay. This assay involves the conversion of nonfluorescent AUR to fluorescent resorufin providing a direct measure for H 2 
and NADH production
Hydrogen peroxide and NADH production by purified PDH and OGDH of porcine heart origin were measured simultaneously as described previously [13, 14] 
Polarographic assessment of mitochondrial respiration
The effect of sodium formate on mitochondrial respiration was monitored using an Oxytherm electrode system (Hansatech). Mitochondria were first diluted to 8 mgÁmL À1 and incubated for 30 min at 37°C in the presence of pyruvate (10 mM) and malate (2 mM) to remove any endogenous ADP remaining in the matrix. Mitochondria were then diluted to 0.5 mgÁmL À1 in the Oxytherm electrode chamber containing respiration buffer (MESH-B, 10 mM KH 2 PO 4 , 5 mM MgCl 2 , pH 7.4) and incubated in sodium formate for 5 min. After obtaining a stable baseline signal, pyruvate (10 mM) and malate (2 mM) were injected in the reaction chamber to assess state 2 respiration. State 3 respiratory conditions (phosphorylating respiration) were then examined by adding ADP (0.5 mM). Oligomycin (4 lgÁmL À1 ), an inhibitor for ATP synthase, was then injected into the reaction mixture to assess state 4 respiration (nonphosphorylating respiration-proton leaks). Reactions were stopped by the addition of antimycin A (4 lM). Respiratory control ratios were calculated as the ratio of state 3 to state 4 respiration.
Cytochrome c oxidase activity assays
Cytochrome c oxidase (COX) activity was monitored using the Oxytherm electrode and TMPD, a substrate for cytochrome c. TMPD is oxidized by cytochrome c which can drive the reduction in O 2 by COX. Ascorbate is added to prevent the auto-oxidation of TMPD. Mitochondria were pretreated with pyruvate and malate as described above. Samples were then diluted to 0.5 mgÁmL À1 in the Oxytherm reaction chamber containing 1 mL respiration buffer and sodium formate. After a 5-min incubation period, ascorbate (2 mM) and TMPD (0.5 mM) were injected into the reaction chamber and the consumption of O 2 was tracked for 2-3 min.
Assessment of mitochondrial membrane potential
The effect of sodium formate on membrane potential was monitored using TMRE under quench mode conditions. Mitochondria were diluted to 3 mgÁmL À1 in MESH-B containing sodium formate and incubated for 15 min at 37°C. Samples were then diluted to 0.1 mgÁmL À1 in reaction chambers containing MESH-B and pyruvate (50 lM) and malate (50 lM) or succinate (50 lM) and then incubated for an additional 5 min. TMRE was then loaded into each reaction chamber to a final concentration of 10 nM. Our group has established that this concentration results in the auto-quenching of TMRE fluorescence which is inversely proportional to membrane potential strength (e.g., higher potential = lower fluorescence) [8] . Samples were incubated for 1 min and changes in TMRE fluorescence measured (Ex:Em = 549 nm/575 nm) using a Biotek Synergi microplate reader.
NAD(P)H measurements
Mitochondrial NAD(P)H levels were measured as described in [15] . Samples were diluted to 3 mgÁmL À1 and incubated in different concentrations of sodium formate with/without antimycin A (4 lM) as described above. Reaction chambers were then loaded with pyruvate (50 lM) and malate (50 lM) and incubated for an additional 5 min. NAD(P)H levels were tracked via its autofluorescence (Ex:Em, 376 nm/420 nm) using a Biotek Synergi microplate reader.
Examination of circulating formate levels
For serum sample collection, mice were kept anesthetized with 5% isoflurane. Using a heparinized syringe, blood was collected by cardiac puncture and then stored on ice. Whole blood was centrifuged at 2300 9 g for 5 min at room temperature and then plasma was collected and stored at À80°C. Circulating formate levels were determined by an isotope dilution GC-MS assay as described by Lamarre et al. [16] . All analyses were performed in duplicate.
Data analysis
All experiments were performed four times and at least in duplicate. Results were analyzed using Graphpad Prism 6. 1-way ANOVA with a post hoc Fisher's LSD test was utilized to test for significance.
Results
Sodium formate augments mitochondrial O
ÁÀ
/ H O production
The formate concentration in plasma collected from C57BL/6N mice used to prepare liver mitochondria was determined to be 27.17 AE 4.71 lM (n = 6). This confirms that the physiological concentration of formate in the blood stream is~0.03 mM [17] . Supplementing mitochondria with 0.03 mM sodium formate induced a significant increase in O ÁÀ 2 /H 2 O 2 release from mitochondria metabolizing pyruvate and malate ( Fig 1A) . In addition, the rate of O ÁÀ 2 /H 2 O 2 formation remained significantly higher than control at sodium formate concentrations greater than 0.03 mM ( Fig 1A) (Fig 1A) . At a final concentration of 10 mM, sodium formate did induce a small but significant increase in ROS production during succinate metabolism. It is important to emphasize that succinate metabolism generates ROS exclusively from the respiratory chain, whereas pyruvate and malate oxidation drive O ÁÀ 2 /H 2 O 2 formation from the respiratory chain, OGDH in the Krebs cycle, and PDH (Fig 1B) [18, 19] . It is unknown if formate can auto-oxidize AUR to its fluorescent resorufin product. Thus, we tested if (a) formate could auto-oxidize AUR and (b) formate alone could augment mitochondrial ROS production. Figure 1C demonstrates that formate does not autooxidize AUR reagent. In addition, formate did not induce O ÁÀ 2 /H 2 O 2 production in reaction mixtures containing only mitochondria (Fig 1C) . This is in contrast to reaction mixtures containing mitochondria and 50 lM pyruvate/50 lM malate. Moreover, supplementing reaction mixtures containing mitochondria and pyruvate/malate with formate (30 lM) induced a significant increase in O ÁÀ 2 /H 2 O 2 production when compared to untreated mitochondria oxidizing pyruvate, confirming results collected in Figure 1A (Fig 1C) . Based on this, we can conclude that the significant increase in O ÁÀ 2 /H 2 O 2 release during pyruvate oxidation is not associated with the auto-oxidation of AUR or the formate-induced production of ROS in mitochondria not supplemented with an oxidizable substrate.
Changes in membrane potential have been documented to influence the rate of O ÁÀ 2 /H 2 O 2 production by mitochondria [20] . Thus, we decided to test if there were any membrane potential changes in samples treated with sodium formate. Figure 2 demonstrates that sodium formate supplementation does not alter membrane potential in mitochondria metabolizing pyruvate and malate. In addition, no fluctuation in membrane potential was observed when succinate served as the substrate (Fig 2B) . Collectively, these results indicate that (a) supplementation of liver mitochondria with a physiological concentration of sodium formate results in a membrane potential-independent increase in O ÁÀ 2 / H 2 O 2 production when pyruvate is being oxidized and (b) high levels of sodium formate are not associated with any aberrant changes in ROS production or membrane potential.
Sodium formate increases state 3 respiration but does not alter mitochondrial ATP production
The other main determinants for O ÁÀ 2 /H 2 O 2 formation are the concentration of the electron donor, the redox state of the electron donating prosthetic group, and accessibility of the ROS forming site to O 2 . Therefore, mitochondrial O ÁÀ 2 /H 2 O 2 production can also be affected by the efficiency of electron flow in the respiratory chain. Thus, we decided to examine the impact of formate on mitochondrial respiration. Mitochondria were treated sequentially with pyruvate and malate, ADP, and oligomycin to test the effect of sodium formate supplementation on the state 2, state 3, and state 4 respiration (Fig 3A, left panel) . Antimycin A was added at the end to inhibit respiration and measure O 2 consumption not associated with the respiratory chain. Sodium formate did not induce any significant change in state 2 respiration even at a final concentration of 10 mM (Fig 3A) . To our surprise, physiological levels of sodium formate supplementation induced a 2 /H 2 O 2 production was measured following the addition of pyruvate (50 lM) and malate (50 lM) or succinate (50 lM). n = 6, mean AE SEM, one-way ANOVA with a post hoc Fisher's LSD test. *P < 0.05, **P < 0.01, ***P < 0.001. (B) Metabolism of pyruvate/malate or succinate results in the development of two different mitochondrial ROS production profiles. Succinate metabolism only results in ROS production by Complexes I, II, and III of the electron transport chain. Pyurvate/malate metabolism induces ROS formation by PDH and OGDH as well as respiratory complexes I, II, and III. Based on this, the source of ROS in liver mitochondria treated with formate can be determined to be either the Krebs cycle and PDH or the electron transport chain. (C) Formate does not interfere with the AUR assay or increase O ÁÀ 2 /H 2 O 2 production by mitochondria in the absence of substrate. AUR assay reagents were treated with formate alone, mitochondria alone, formate and mitochondria, or mitochondria oxidizing pyruvate (50 lM) and malate (50 lM) in the absence or presence of formate. n = 4, mean AE SEM, one-way ANOVA with a post hoc Fisher's LSD test. *P < 0.05, ***P < 0.01. significant increase in phosphorylating state 3 respiration (Fig 3A) . In addition, this effect seemed to be concentration dependent since higher amounts of sodium formate induced higher rates of state 3 respiration. Finally, sodium formate supplementation did not significantly alter proton leaks (state 4) (Fig 3A) . Next, we calculated the respiratory control ratio, a proxy measure for the efficiency of mitochondrial ATP production. No significant change in RCR was observed despite the formate-induced increase in state 3 respiration (Fig 3B) . We attribute this to discrepancies in state 4 respiration where sodium formate induced small but insignificant changes in proton leaks (Fig 3A  and B) . This could offset the ATP-forming efficiency of mitochondria even if state 3 respiration is increased. Overall, formate does not compromise mitochondrial respiration or ATP-forming capacity, and augments phosphorylating respiration.
Impact of sodium formate on COX activity and NAD(P)H levels
It has been documented that high formate (upwards to 30 mM) can inhibit COX activity in isolated mitochondria and submitochondrial particles [10] . Even though we observed that formate does not compromise mitochondrial respiration, we decided to test if sodium formate could affect COX activity. Mitochondria were incubated in sodium formate and then the TMPDmediated reduction of O 2 was monitored using an Oxytherm electrode (Fig 4A, left panel) . It was found that sodium formate treatment did not alter COX-mediated O 2 consumption (Fig 4A) . These results confirm the observation that formate does not compromise mitochondrial respiration. In an effort to ascertain how formate, in the presence of pyruvate and malate, could augment mitochondrial O ÁÀ 2 /H 2 O 2 production, we examined its effect on the NAD(P)H pool. The NADH/NAD ratio is another important factor that influences mitochondrial ROS production [21] and proxy measures of the reduced state of mitochondrial nicotinamide nucleotide pools are routinely utilized to correlate changes in NADH with O ÁÀ 2 /H 2 O 2 production [15] . As shown in Figure 4B , inclusion of sodium formate did not alter the redox state of the nicotinamide nucleotide pool in mitochondria metabolizing pyruvate and malate. We also performed these measurements in the presence of antimycin A which inhibits Complex III preventing NADH turnover at the level of Complex I. As expected, antimycin A induced an increase in NAD(P)H levels ( Fig 4B) . However, no changes in NAD(P)H levels were observed in sodium formate supplemented samples. These results indicate that the formate-induced change in pyruvate/malate-driven ROS production is not associated with the inhibition of COX or alterations in NAD(P)H levels. [13, 15] . Indeed, PDH and OGDH produce~4 9 and~8 9 more ROS than Complex I in muscle mitochondria [15] . It has also been found that OGDH is a major source of ROS in liver mitochondria, whereas PDH makes a minor contribution [22] . Using site-specific inhibitors for PDH and OGDH, we tested whether either enzyme complex could account for the formate-induced increase in mitochondrial ROS production. For this we used 3-methyl-2-ketovaleric acid (KMV), a 2-oxoglutarate analog and OGDH inhibitor, and CPI-613, a lipoic acid analog which has been documented to interfere with the dihydrolipoamide containing E 2 subunit of PDH and OGDH (Fig 5A) [19] . As shown in Figure (Fig 5B) . Notably, the formate effect was blunted by KMV and CPI-613. We observed that inclusion of KMV and CPI-613 in mitochondria treated with 0.03 mM sodium formate induced an approximately sevenfold and approximately fourfold decrease, respectively, in O ÁÀ 2 /H 2 O 2 production relative to control samples (KMV =~4-fold, CPI-613 =~2-fold decrease). Moreover, KMV and CPI-613 were just as effective at inhibiting O ÁÀ 2 /H 2 O 2 production in formate-treated mitochondria as in control samples (Fig 5B) . Indeed, KMV lowered ROS production during pyruvate oxidation by~78-84% in mitochondria treated with or without sodium formate. Similar observations were made with CPI-613 except it only inhibited ROS production by~60% in control mitochondria, whereas a~75% decrease was observed with mitochondria supplemented with sodium formate. Mitochondria were added to the Oxytherm electrode chamber (0.5 mg/mL final concentration), treated with sodium formate, and then the different states of respiration were measured using pyruvate (10 mM) and malate (2 mM) as substrates. n = 4, mean AE SEM, one-way ANOVA with a post hoc Fisher's LSD test.
Our group recently showed that~150 lM CPI-613 and at least 1 mM KMV was required to induce maximal inhibition (~90%) of pyruvate-driven ROS production in liver mitochondria and that both compounds are equally effective at limiting O (Fig 5C) . However, supplementing reaction mixtures with GSH (2 mM) alone induced a significant increase in O ÁÀ 2 /H 2 O 2 release without affecting NADH production, an observation consistent with a previous study [24] . Supplementing reaction mixtures with formate and GSH induced a significant Mitochondria were added to the Oxytherm electrode chamber (0.5 mg/mL final concentration), treated with sodium formate, and then COX activity was measured using TMPD (0.5 mM) and ascorbate (2 mM). (B) Mitochondria were treated with formate with or without antimycin A (4 lM) and then changes in NAD(P) H were tracked by changes in its autofluorescence. Pyruvate (50 lM) and malate (50 lM) served as substrates. n = 4, mean AE SEM, oneway ANOVA with a post hoc Fisher's LSD test. *P < 0.05, **P < 0.01, ***P < 0.001. production by purified PDH (C) and OGDH (D) in the presence of GSH without altering its enzyme activity. Purified PDH and OGDH were treated with formate alone, GSH alone, or GSH with formate and then O ÁÀ 2 /H 2 O 2 and NADH production were measured simultaneously n = 4, mean AE SEM, one-way ANOVA with a post hoc Fisher's LSD test. *P < 0.05, **P < 0.01, ***P < 0.001.
increase in O ÁÀ
2 /H 2 O 2 production relative to control reactions (no formate or GSH) and reactions containing GSH (Fig 5C) . Similar results were obtained with purified OGDH of porcine heart origin. Indeed, supplementing reaction mixtures with formate alone did not alter O ÁÀ 2 /H 2 O 2 release or OGDH activity (Fig 5D) . In contrast, addition of GSH induced a significant increase in O ÁÀ 2 /H 2 O 2 production which was augmented further by formate (Fig 5D) . OGDH activity (NADH production) was not altered under all reaction conditions.
Discussion
Mitochondria play an integral role in the provision of one-carbon groups for cell growth and proliferation. It has also become evident that metabolites involved in one-carbon metabolism, such as choline and dimethylglycine, can also promote mitochondrial ROS production [8] . Liver mitochondria serve as sources and sinks for formate, another critical one-carbon metabolite, that can be used to form NADPH and 10-formyltetrahydrofolate [3] . Here, we found that sodium formate supplementation alters mitochondrial O ÁÀ 2 /H 2 O 2 production and respiration. It was observed that supplying mitochondria with a physiologically relevant concentration of sodium formate induced a significant increase in O ÁÀ 2 /H 2 O 2 production during pyruvate and malate oxidation. Intriguingly, this effect was not observed in mitochondria metabolizing succinate. The change in ROS production was not associated with any alterations in mitochondrial respiration, membrane potential, COX activity, or fluctuations in NAD (P)H levels, factors which are known to affect O ÁÀ 2 / H 2 O 2 production. Sodium formate supplementation also elevated phosphorylating respiration. Finally, using specific inhibitors for PDH and OGDH, it was found that the source for formate-induced ROS production was the Krebs cycle. Collectively, these results demonstrate that at a physiological concentration, sodium formate can augment mitochondrial ROS emission without disrupting respiration or bioenergetics. These characteristics may allow formate to serve as an inducer of mitochondrial ROS signaling for the induction of cell proliferation.
Mitochondria treated with sodium formate increased pyruvate-and malate-driven ROS production. Pyruvate oxidation results in the formation of acetyl-CoA which condenses with oxaloacetate to form citrate. The addition of malate allows for the generation of oxaloacetate and thus primes the Krebs cycle for the full oxidation of acetyl-CoA. PDH and OGDH serve as important sources of ROS in liver, muscle, and brain mitochondria, oxidizing substrates that feed directly into the Krebs cycle [11, 13, 18] . In fact, PDH and OGDH have been shown to form~4 9 and 8 9 more ROS than Complex I in muscle mitochondria [15] . By contrast, our group has shown that OGDH and Complex III are high-capacity O ÁÀ 2 /H 2 O 2 -forming sites in liver mitochondria oxidizing pyruvate and malate with PDH making a minor contribution [13, 22] . In the present study, it was observed that sodium formate did not alter succinate-driven ROS production. Primary sites for ROS production by mitochondria oxidizing only succinate are Complexes I, II, and III. Membrane potential, NAD(P)H levels, and efficiency of electron flux to O 2 , important factors that influence O ÁÀ 2 /H 2 O 2 production, were not altered by the presence of formate indicating that the source of ROS is not the electron transport chain. Since ROS production was elevated only when pyruvate and malate served as substrates, it can be concluded that sodium formate increased O ÁÀ 2 /H 2 O 2 upstream from the electron transport chain. Similar observations have been made with male Wistar rats subjected to methionine restriction, an amino acid involved in onecarbon metabolism [25] . Using liver mitochondria it was observed that the limitation of methionine decreases glutamate/malate-driven ROS production without affecting O ÁÀ 2 /H 2 O 2 formed by succinate [25] . We also found that KMV, a structural analog for 2-oxoglutarate, and CPI-613, a lipoic acid analog and putative PDH and OGDH inhibitor, induced añ 80% decrease in ROS emission from mitochondria supplemented with sodium formate. It was previously found that Complex III accounts for~45% of the total ROS emitted from mitochondria metabolizing pyruvate and malate, whereas OGDH contributed 30% [22] . PDH and other sources like Complex I made up the remaining~15%. It is vital to point out that succinate, which forms a large fraction of its ROS via Complex III, did not augment ROS production. Therefore, we propose that sodium formate enhances ROS emission from OGDH and perhaps to a much lesser extent from PDH.
In the present study, GSH in the presence of formate augmented O ÁÀ 2 /H 2 O 2 production by purified OGDH and PDH, respectively. It has been known for some time that OGDH can undergo reversible S-glutathionylation which controls its activity [26] . S-glutathionylation also controls O ÁÀ 2 /H 2 O 2 release from OGDH [19, 24] . It was also found that the S-glutathionylation state of OGDH is dictated by the relative levels of GSH and GSSG [24] . GSH can S-glutathionylate OGDH, augmenting ROS production (EC 50 = 2.125 mM GSH [24] . This is achieved through the S-glutathionylation of the E1 subunit of OGDH which is hypothesized to augment ROS production through TPP radical accumulation [24, 27] . Here, we have confirmed that GSH (2 mM) can amplify O ÁÀ 2 / H 2 O 2 release by OGDH. However, it was also found that this GSH effect can be augmented by sodium formate supplementation. Formate alone did not alter the activity or ROS producing capacity of OGDH and did not directly interfere with the AUR assay. In addition, similar observations were made with purified PDH of porcine heart origin. PDH has been shown recently to undergo S-glutathionylation [19, 28] . Moreover, it was found that all three PDH subunits can be subjected to S-glutathionylation [19] . OGDH produces ROS via its TPP and FAD groups found in the E1 and E3 subunits, respectively [29] . However, there is no evidence to suggest that PDH can form ROS by its E1 subunit. Since OGDH and PDH are highly homologous in terms of their basic structure, it is plausible that (a) the E1 subunit in PDH can also produce O In the present study, it was also observed that sodium formate augmented phosphorylating respiration. It is entirely possible that formate may exert this effect by producing NADPH which can alter mitochondrial redox buffering capacity through the maintenance of a more reduced glutathione pool. This could feasibly increase mitochondrial electron flow through the respiratory chain since the respiratory complexes operate optimally when the mitochondrial redox environment is more reducing [30] . For example, the phosphorylation of ADP by ATP synthase is decreased when mitochondrial redox-buffering pools are more oxidized which is associated with the oxidative modification of different subunits within the respiratory complex [30, 31] . Another possibility is that formate metabolism results in ATP turnover in the matrix [9] . Indeed, during the formation of 10-formyltetrahydrofolate, ATP is hydrolyzed which can lead to the provision of ADP for state 3 respiration. Other systems that are required to maintain the ADP pool for phosphorylating respiration have been documented in mitochondria. For instance, hexokinase IV has been shown to absorb to the mitochondrial outer membrane where it couples the phosphorylation of glucose with the formation of ADP. The result is the use of a small fraction of the ATP exported from mitochondria to preserve ADP levels for respiration [32] . It needs to be emphasized that formate is potentially toxic especially at a high concentration [17] . Considering that formate has been reported to inhibit COX activity, we hypothesized that COX inhibition could result in increased ROS production which could be responsible for its toxicity [10] . However, in the present study we found no evidence that formate, even at an elevated concentration, could negatively affect mitochondrial metabolism or bioenergetics. Moreover, sodium formate did not alter COX activity. This is in contrast to two previous studies where it was found that formate interfered with COX [10, 33] . However, most of these studies were carried out with submitochondrial particles, meaning that this system lacked the matrix enzymes required to metabolize formate. In addition, these studies utilized millimolar amounts of formate. For example, 7.25 mM sodium formate was required to inhibit COX by~50% in submitochondrial particles [10] . In addition, the calculated K i for COX was 25-38 mM formate and a concentration of 60 mM was required to inhibit state 3 respiration in intact mitochondria [33] . This is in contrast to our study which used intact mitochondria, physiological substrate concentrations (50 lM pyruvate or succinate), and formate concentrations that were in the physiological or pharmacological range. Indeed, formate supplementation of pregnant curly tailed mice to reduce the incidence of NTDs resulted in formate levels of approximately 600 lM [7] . This is consistent with the lack of toxic effects at physiological concentrations examined in the present study. In aggregate, it was found that formate, another important one-carbon metabolite, can also promote mitochondrial ROS production. This effect was not associated with any aberrant changes in mitochondrial bioenergetics. Intriguingly, the increase in ROS production occurred when mitochondria were treated with 30 lM sodium formate which is considered to be its physiological concentration. Mitochondria have been reported to be an important site for formate toxicity. However, in our study we found no evidence that a high formate concentration interferes with mitochondrial function. Rather, it would appear that at a physiological concentration, sodium formate promotes mitochondrial ROS production from the Krebs cycle and PDH. Mitochondrial ROS, in particular H 2 O 2 , serve as secondary messengers required for the induction of cell division, differentiation, and growth [34] . Notably, cell division is also usually associated with increased glucose metabolism and pyruvate oxidation which has been shown to promote mitochondrial O ÁÀ 2 /H 2 O 2 production [35] . We propose that the formate-induced increase in mitochondrial O ÁÀ 2 / H 2 O 2 release could serve as a co-signal required for cell growth and division which may play an integral role in the prevention of folic acid-resistant NTDs.
